SCHEMBL3425558

SCHEMBL3425558

CN(CCOCCN(C)c1c(S(=O)(=O)C(F)(F)F)c(C#N)nn1-c1c(Cl)cc(C(F)(F)F)cc1Cl)c1c(S(=O)(=O)C(F)(F)F)c(C#N)nn1-c1c(Cl)cc(C(F)(F)F)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRB3 P28472 16/20 0.43
GABRA2 P47869 13/20 0.43
GABRB2 P47870 13/20 0.43
GABRP O00591 10/20 0.43
GABRD O14764 10/20 0.43
GABRA1 P14867 10/20 0.43
GABRB1 P18505 10/20 0.43
GABRG2 P18507 10/20 0.43
GABRA5 P31644 10/20 0.43
GABRA3 P34903 10/20 0.43
GABRA4 P48169 10/20 0.43
GABRE P78334 10/20 0.43
GABRA6 Q16445 10/20 0.43
GABRG1 Q8N1C3 10/20 0.43
GABRG3 Q99928 10/20 0.43
GABRQ Q9UN88 10/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NR1I2 O75469 1/20 0.43
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6624975 0.94 GABRB3 (0.42) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL1267183 0.90 GABRB3 (0.43) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL3259440 0.90 GABRB3 (0.43) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL1266754 0.88 GABRB3 (0.39) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL4415803 0.88 GABRB3 (0.42) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL1266854 0.87 GABRB3 (0.37) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL1267967 0.87 GABRP (0.37) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL6055588 0.86 GABRB3 (0.48) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL709516 0.85 GABRB3 (0.43) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL3579966 0.85 GABRB3 (0.43) GABRB3GABRA2GABRB2GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761502-B1 N-PHENYLPYRAZOLE DERIVATIVES AS PESTICIDES MERIAL LTD (US) 2013-12-18 EP disclosed
US-7662961-B2 5,5'-{Oxybis[ethane-2,1-diyl(methylimino)]}bis[1-(2,6-dichloro-4-trifluoromethylphenyl)-3-cyano-4-trifluoromethylsulfonylpyrazole]; pest control of insects, arachnids and helminths MERIAL LIMITED (US) 2010-02-16 US disclosed
US-20070275976-A1 N-PHENYLPYRAZOLE DERIVATIVES AS PESTICIDES MERIAL LIMITED 2007-11-29 US disclosed
EP-1761502-A1 N-PHENYLPYRAZOLE DERIVATIVES AS PESTICIDES Merial Limited (US) 2007-03-14 EP disclosed
WO-2006000313-A1 N-PHENYLPYRAZOLE DERIVATIVES AS PESTICIDES MERIAL LTD. (US) 2006-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275976-A1 N-PHENYLPYRAZOLE DERIVATIVES AS PESTICIDES DDT, CYP3A5, PTMS GABRB3 1010/4885GABRA2 1399/4885GABRB2 1430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.